PTSD — Neurobiology and mechanism¶
TL;DR — PTSD is best modelled as interacting learning, memory, threat-detection, autonomic and endocrine processes rather than one lesion or biomarker. Fear extinction and safety learning provide a treatment-relevant framework, while HPA-axis and neuroimaging findings are group-level and heterogeneous (Pitman 2012, PMID 23047775) (Abdallah 2017, PMID 28478864). Meta-analyses of cortisol show inconsistency across specimen, time and comparator definitions (Pan 2018, PMID 30290789) (Pan 2020, PMID 31918435). Mechanistic findings shared with depression or pooled anxiety disorders are not evidence of PTSD specificity.
Threat learning¶
Conditioned fear acquisition is not itself PTSD. The clinically relevant problems include overgeneralisation, impaired discrimination of safety, context-dependent extinction retrieval and persistent avoidance (Shin 2006, PMID 16891563) (Rauch 2006, PMID 16919525). Exposure therapies test whether corrective learning can occur without erasing autobiographical memory.
Memory¶
Intrusive recollection, fragmentation and voluntary recall are distinct. Reconsolidation interventions attempt to alter a retrieved memory under specific timing conditions; clinical translation remains less settled than the laboratory rationale (Friedman 2018, PMID 29712466) (Waits 2018, PMID 30380933) (Giustino 2016, PMID 26808441).
HPA axis¶
Lower or altered cortisol has been reported, but direction and magnitude depend on trauma-exposed versus unexposed controls, comorbid depression, sex, medication, sampling time and chronicity (Pan 2018, PMID 30290789) (Pan 2020, PMID 31918435). Depression can show a different HPA pattern, so comorbidity must be modelled rather than absorbed.
Circuits and imaging¶
Amygdala, hippocampal and medial prefrontal findings motivate threat/context models, but average group differences do not diagnose individuals. Medication, trauma exposure and symptom dimensions are major confounders (Pitman 2012, PMID 23047775) (Abdallah 2017, PMID 28478864) (Maren 2016, PMID 26105142).
Autonomic and inflammatory candidates¶
Reduced resting respiratory sinus arrhythmia showed a pooled association across 55 studies, not a validated diagnostic marker (Campbell 2019, PMID 30779926). TSPO PET and immune findings remain small-sample, method-sensitive candidates (Watling 2023, PMID 36973385).
Causal inference¶
A correlate measured after years of symptoms may be vulnerability, consequence, compensation or treatment effect. Prospective pre-trauma cohorts, genetically informed designs and perturbation studies are the designs that separate these, and the small number that exist show the separation is real rather than theoretical. In 221 police recruits scanned before trauma exposure, heightened dorsal amygdala responsivity and amygdala–precuneus coupling during threat anticipation predicted a stronger subsequent rise in post-traumatic stress symptoms, whereas increased lateral amygdala activation to an aversive shock tracked the experience of traumatic events independently of symptoms — a predisposing and an acquired signal in the same structure (de Voogd 2025, PMID 40024495). A pre-deployment study of 643 male service members similarly found that poor threat/safety discrimination before trauma predicted new-onset PTSD, while slower pre-trauma extinction learning predicted severity rather than caseness (Acheson 2025, PMID 41103636). Both cohorts are occupationally selected and predominantly male.
Quantitative anchors¶
| Measure | Estimate | Population/method | Source |
|---|---|---|---|
| Biological review | multiple levels | psychophysiology, imaging, endocrine, molecular | (Pitman 2012, PMID 23047775) |
| Salivary cortisol | systematic review/meta-analysis | Comparator and sampling heterogeneity | (Pan 2018, PMID 30290789) |
| 24-h urinary cortisol | 20 eligible studies | Random-effects meta-analysis | (Pan 2020, PMID 31918435) |
| Resting RSA | 55 studies; n=6,689 | 12 unpublished studies included; g=−0.26 (95% CI −0.35 to −0.16) | (Campbell 2019, PMID 30779926) |
| 24-h urinary cortisol, PTSD vs control | SMD −0.49 (95% CI −0.91 to −0.07), p=0.02 | 20 of 619 screened studies | (Pan 2020, PMID 31918435) |
| Pre-trauma amygdala | dorsal amygdala predicts symptom rise; lateral tracks exposure | 221 police recruits | (de Voogd 2025, PMID 40024495) |
| Pre-trauma fear learning | poor threat/safety discrimination predicts new-onset PTSD | 643 male service members | (Acheson 2025, PMID 41103636) |
Evidence ledger¶
The ledger lists the live-retrieved records used to bound this page. Inclusion does not make every record equally probative; design, population and comparator remain decisive.
| PMID | Year | Evidence contribution | Scope caution |
|---|---|---|---|
| 23047775 | 2012 | Biological studies of post-traumatic stress disorder. | PTSD-specific record; inspect design and population |
| 16891563 | 2006 | Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. | PTSD-specific record; inspect design and population |
| 16919525 | 2006 | Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future. | PTSD-specific record; inspect design and population |
| 28478864 | 2017 | Neurobiology of posttraumatic stress disorder (PTSD): A path from novel pathophysiology to innovative therapeutics. | PTSD-specific record; inspect design and population |
| 26105142 | 2016 | Stress and Fear Extinction. | PTSD-specific record; inspect design and population |
| 31759567 | 2020 | Imaging of Posttraumatic Stress Disorder. | PTSD-specific record; inspect design and population |
| 29734227 | 2018 | Fear Processing, Psychophysiology, and PTSD. | PTSD-specific record; inspect design and population |
| 27590828 | 2016 | Understanding posttraumatic stress disorder through fear conditioning, extinction and reconsolidation. | PTSD-specific record; inspect design and population |
| 29754704 | 2018 | Genetic Advances in Post-traumatic Stress Disorder. | PTSD-specific record; inspect design and population |
| 9670231 | 1998 | Psychoneuroendocrinology of post-traumatic stress disorder. | PTSD-specific record; inspect design and population |
| 30290789 | 2018 | Salivary cortisol in post-traumatic stress disorder: a systematic review and meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 31918435 | 2020 | The 24-hour urinary cortisol in post-traumatic stress disorder: A meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 30779926 | 2019 | Resting respiratory sinus arrhythmia and posttraumatic stress disorder: A meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 36973385 | 2023 | Investigating TSPO levels in occupation-related posttraumatic stress disorder. | PTSD-specific record; inspect design and population |
| 29712466 | 2018 | Eradicating Traumatic Memories: Implications for PTSD Treatment. | PTSD-specific record; inspect design and population |
| 30380933 | 2018 | Reconsolidation of Traumatic Memories Using Psychotherapy. | PTSD-specific record; inspect design and population |
| 26808441 | 2016 | Revisiting propranolol and PTSD: Memory erasure or extinction enhancement? | PTSD-specific record; inspect design and population |
| 10795605 | 2000 | Biology of posttraumatic stress disorder. | PTSD-specific record; inspect design and population |
| 11495096 | 2001 | Biology of posttraumatic stress disorder. | PTSD-specific record; inspect design and population |
| 9329447 | 1997 | The psychobiology of posttraumatic stress disorder. | PTSD-specific record; inspect design and population |
| 1661614 | 1991 | Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. | PTSD-specific record; inspect design and population |
| 36048486 | 2022 | Combining Molecular and Neuroimaging Measures to Understand Psychopathology and Inform New Treatment Development. | PTSD-specific record; inspect design and population |
| 36982313 | 2023 | To Predict, Prevent, and Manage Post-Traumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers. | Synthesis: preserve included-population and certainty limits |
| 39316444 | 2024 | Stimulation of an entorhinal-hippocampal extinction circuit facilitates fear extinction in a post-traumatic stress disorder model. | PTSD-specific record; inspect design and population |
| 39842807 | 2025 | On the role of epigenetic modifications of HPA axis in posttraumatic stress disorder and resilience. | PTSD-specific record; inspect design and population |
| 34734742 | 2021 | Abuse and Delayed Brain Maturation in Girls: The Cost of Lagging Behind. | PTSD-specific record; inspect design and population |
| 33517750 | 2021 | Functional Neuroimaging in PTSD: From Discovery of Underlying Mechanisms to Addressing Diagnostic Heterogeneity. | PTSD-specific record; inspect design and population |
| 40024495 | 2025 | Amygdala Hyperactivity in Posttraumatic Stress Disorder: Disentangling Predisposing From Consequential Factors Using a Prospective Longitudinal Design. | Prospective; occupationally selected cohort |
| 41103636 | 2025 | A prospective study of pre-trauma fear learning and extinction as risk factors for posttraumatic stress disorder. | Prospective; male military cohort |
Interpretation guardrails¶
- Trauma exposure, post-traumatic symptoms, acute stress disorder, DSM-5 PTSD, ICD-11 PTSD and ICD-11 complex PTSD are not interchangeable populations.
- A mixed-anxiety or transdiagnostic estimate is labelled as such; only a source’s PTSD stratum can be treated as a PTSD effect.
- Comorbid depression is measured separately and cross-linked to the depression condition; it is not absorbed into PTSD.
- Waitlist, treatment-as-usual, attention control and active treatment answer different causal questions.
- Registration, statistical significance and diagnostic loss do not respectively prove completion, clinical importance or functional recovery.
- This page synthesizes research and does not provide individual medical advice.
Minimum extraction frame for studies on this topic¶
| Field | What must be retained | Why it changes interpretation |
|---|---|---|
| Diagnostic system | DSM version, ICD version, full/subthreshold | Case mix is not interchangeable |
| Diagnostic method | Structured interview, clinician judgment, self-report cutoff | Screening is not diagnosis |
| Index trauma | Type, timing, repetition, direct/indirect/occupational | Conditional risk and phenotype differ |
| Population | Civilian, veteran, refugee, child/adolescent, mixed | Transportability is empirical |
| Baseline severity | Mean, SD, range and exclusion threshold | Ceiling and floor effects alter change |
| CPTSD status | ITQ/ICD-11 definition and DSO score | Complexity cannot be inferred from trauma count |
| Comorbidity | Depression, GAD, SUD, pain, TBI measured separately | Shared symptoms can distort effects |
| Comparator | Waitlist, usual care, attention, active treatment | The estimand changes with comparator |
| Treatment dose | Sessions offered/attended, duration, homework | Assignment is not exposure |
| Outcome | Symptoms, diagnosis, response, function, sleep | Outcomes are not interchangeable |
| Time point | End point and prespecified follow-up windows | Acute benefit may not persist |
| Missing data | Denominator, reasons, imputation and estimand | Attrition can bias rank and magnitude |
| Adverse events | Definitions, ascertainment and arm-level counts | Absence of reporting is not absence of harm |
| Therapist/context | Training, fidelity, allegiance, setting | Delivery is part of the intervention |
| Funding/conflicts | Sponsor role and analytic independence | Especially material for proprietary packages |
Claims this page does not make¶
- It does not infer PTSD from trauma exposure alone.
- It does not treat a self-report cutoff as equivalent to a structured diagnosis.
- It does not convert a pooled anxiety-disorder effect into a PTSD effect.
- It does not convert a depression outcome in a comorbid sample into a PTSD outcome.
- It does not infer superiority from a statistically significant within-group change.
- It does not infer equivalence from a non-significant between-group test.
- It does not infer effectiveness from trial registration or mechanistic plausibility.
- It does not assume military, civilian, refugee and pediatric estimates transport unchanged.
- It does not average conflicting estimates that use different definitions.
- It does not treat lack of adverse-event reporting as evidence of safety.
Evidence-updating triggers¶
| Trigger | Required response |
|---|---|
| New diagnostic revision | Recalculate which populations prior estimates represent |
| New head-to-head RCT | Compare against active treatment, not only waitlist |
| New individual-participant synthesis | Revisit effect modifiers and transportability |
| Registry status change | Verify results and linked publication before changing conclusions |
| Guideline update | Separate evidence review from panel recommendation |
| Regulatory decision | Record decision date and source; do not infer from efficacy papers |
| Safety signal | Re-extract denominator, ascertainment and exposure time by arm |
| Contradictory replication | Display estimates side by side; do not average definitions |
Evidence updates should preserve the prior estimate and explain why the new study changes—or does not change—the inference.
Open questions¶
- Which mechanistic measures predict differential response to PE, CPT or EMDR prospectively? (McLean 2022, PMID 34954460) (Mavranezouli 2020, PMID 32063234)
- Can extinction/safety-learning tasks achieve test–retest reliability adequate for individual prediction? (Shin 2006, PMID 16891563)
- How much HPA heterogeneity is explained by comorbid depression and sampling protocol? (Pan 2018, PMID 30290789) (Pan 2020, PMID 31918435)
Related pages¶
- prolonged-exposure — clinical translation of extinction learning.
- emdr — working-memory and orienting hypotheses.
- sleep-and-nightmare-treatment — sleep-dependent memory and adrenergic treatment.
- diagnosis-and-classification — why biomarkers do not replace diagnosis.
References¶
- Pitman RK, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012;13(11):769-87. PMID 23047775
- Shin LM, et al. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci. 2006;1071:67-79. PMID 16891563
- Rauch SL, et al. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future. Biol Psychiatry. 2006;60(4):376-82. PMID 16919525
- Abdallah CG, et al. Neurobiology of posttraumatic stress disorder (PTSD): A path from novel pathophysiology to innovative therapeutics. Neurosci Lett. 2017;649:130-132. PMID 28478864
- Maren S, et al. Stress and Fear Extinction. Neuropsychopharmacology. 2016;41(1):58-79. PMID 26105142
- Kamiya K, et al. Imaging of Posttraumatic Stress Disorder. Neuroimaging Clin N Am. 2020;30(1):115-123. PMID 31759567
- Norrholm SD, et al. Fear Processing, Psychophysiology, and PTSD. Harv Rev Psychiatry. 2018;26(3):129-141. PMID 29734227
- Careaga MBL, et al. Understanding posttraumatic stress disorder through fear conditioning, extinction and reconsolidation. Neurosci Biobehav Rev. 2016;71:48-57. PMID 27590828
- Guillén-Burgos HF, et al. Genetic Advances in Post-traumatic Stress Disorder. Rev Colomb Psiquiatr (Engl Ed). 2018;47(2):108-118. PMID 29754704
- Yehuda R Psychoneuroendocrinology of post-traumatic stress disorder. Psychiatr Clin North Am. 1998;21(2):359-79. PMID 9670231
- Pan X, et al. Salivary cortisol in post-traumatic stress disorder: a systematic review and meta-analysis. BMC Psychiatry. 2018;18(1):324. PMID 30290789
- Pan X, et al. The 24-hour urinary cortisol in post-traumatic stress disorder: A meta-analysis. PLoS One. 2020;15(1):e0227560. PMID 31918435
- Campbell AA, et al. Resting respiratory sinus arrhythmia and posttraumatic stress disorder: A meta-analysis. Biol Psychol. 2019;144:125-135. PMID 30779926
- Watling SE, et al. Investigating TSPO levels in occupation-related posttraumatic stress disorder. Sci Rep. 2023;13(1):4970. PMID 36973385
- Friedman MJ Eradicating Traumatic Memories: Implications for PTSD Treatment. Am J Psychiatry. 2018;175(5):391-392. PMID 29712466
- Waits WM, et al. Reconsolidation of Traumatic Memories Using Psychotherapy. Am J Psychiatry. 2018;175(11):1145. PMID 30380933
- Giustino TF, et al. Revisiting propranolol and PTSD: Memory erasure or extinction enhancement? Neurobiol Learn Mem. 2016;130:26-33. PMID 26808441
- Yehuda R Biology of posttraumatic stress disorder. J Clin Psychiatry. 2000;61 Suppl 7:14-21. PMID 10795605
- Yehuda R Biology of posttraumatic stress disorder. J Clin Psychiatry. 2001;62 Suppl 17:41-6. PMID 11495096
- van der Kolk BA The psychobiology of posttraumatic stress disorder. J Clin Psychiatry. 1997;58 Suppl 9:16-24. PMID 9329447
- Yehuda R, et al. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry. 1991;30(10):1031-48. PMID 1661614
- Kalin NH Combining Molecular and Neuroimaging Measures to Understand Psychopathology and Inform New Treatment Development. Am J Psychiatry. 2022;179(9):589-592. PMID 36048486
- Al Jowf GI, et al. To Predict, Prevent, and Manage Post-Traumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers. Int J Mol Sci. 2023;24(6):5238. PMID 36982313
- Lin ZJ, et al. Stimulation of an entorhinal-hippocampal extinction circuit facilitates fear extinction in a post-traumatic stress disorder model. J Clin Invest. 2024;134(22):e181095. PMID 39316444
- Khan Z, et al. On the role of epigenetic modifications of HPA axis in posttraumatic stress disorder and resilience. J Neurophysiol. 2025;133(3):742-759. PMID 39842807
- Stenson AF, et al. Abuse and Delayed Brain Maturation in Girls: The Cost of Lagging Behind. Am J Psychiatry. 2021;178(11):988-990. PMID 34734742
- Neria Y Functional Neuroimaging in PTSD: From Discovery of Underlying Mechanisms to Addressing Diagnostic Heterogeneity. Am J Psychiatry. 2021;178(2):128-135. PMID 33517750
- Mavranezouli I, et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med. 2020;50(4):542-555. PMID 32063234
- McLean CP, et al. Exposure therapy for PTSD: A meta-analysis. Clin Psychol Rev. 2022;91:102115. PMID 34954460
- de Voogd LD, et al. Amygdala Hyperactivity in Posttraumatic Stress Disorder: Disentangling Predisposing From Consequential Factors Using a Prospective Longitudinal Design. Biol Psychiatry. 2025;98(5):427-435. PMID 40024495
- Acheson DT, et al. A prospective study of pre-trauma fear learning and extinction as risk factors for posttraumatic stress disorder. J Mood Anxiety Disord. 2025;12:100148. PMID 41103636